Cardio Diagnostics Holdings (NASDAQ: CDIO) is engaging directly with employers, insurers, and healthcare systems at four national benefits conferences this June, where the company plans to discuss innovative approaches to cardiovascular disease prevention, risk assessment and cost management. The initiative comes as cardiovascular disease remains one of the most expensive health conditions in the United States, driving significant healthcare spending that affects employers and insurers through higher medical costs, lost productivity and long-term care expenses.
According to the American Heart Association (AHA), direct cardiovascular healthcare costs accounted for approximately 11% of all U.S. healthcare expenditures in 2020–2021, more than any major diagnostic group. A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient’s health, affecting employers, insurers and healthcare systems. As organizations responsible for employee benefits seek new strategies to identify risk earlier and improve outcomes, Cardio Diagnostics has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care.
The company's participation in these conferences underscores its commitment to addressing the growing burden of cardiovascular disease on the healthcare system. By engaging directly with stakeholders at events focused on employee benefits, Cardio Diagnostics aims to demonstrate how its precision medicine platform can help employers manage healthcare costs while improving the health of their workforce. The company's solutions leverage advanced genomics and machine learning to assess individual risk and guide personalized prevention strategies.
Cardio Diagnostics' engagement at these conferences is part of a broader effort to expand its reach beyond traditional healthcare providers and into the employer-sponsored insurance market, where cardiovascular disease represents a substantial cost driver. The company's newsroom provides the latest updates and information on its initiatives (https://ibn.fm/CDIO).
Forward-looking statements in this article involve risks and uncertainties, as detailed in the company's filings with the SEC. The full terms of use and disclaimers are available on the InvestorBrandNetwork website (http://IBN.fm/Disclaimer).
